Central Nervous System Stimulant [EPC]

87385 reported adverse events

Drugs of this class: ACETAMINOPHEN, ASPIRIN, CAFFEINE CAFFEINE BUTALBITAL, ACETAMINOPHEN AND CAFFEINE ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE ACETAMINOPHEN, ASPIRIN AND CAFFEINE BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE ACETAMINOPHEN, CAFFEINE ACETAMINOPHEN, ASPIRIN, AND CAFFEINE ASPIRIN AND CAFFEINE ASPIRIN, CAFFEINE ACETAMINOPHEN, CAFFEINE, AND PYRILAMINE MALEATE

These side effects are most commonly reported by patients taking drugs of the Central Nervous System Stimulant [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 11102
1 OFF LABEL USE 9069
2 NO ADVERSE EVENT 7084
3 PRODUCT QUALITY ISSUE 5935
4 HEADACHE 5716
5 NAUSEA 5285
6 PRODUCT USE IN UNAPPROVED INDICATION 5139
7 FATIGUE 5113
8 TOXICITY TO VARIOUS AGENTS 4232
9 PAIN 4039
See all common reactions for Central Nervous System Stimulant [EPC]

Drugs of the Central Nervous System Stimulant [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GRIP STRENGTH 139 0.6070
1 ADHESIVE TAPE USE 167 0.4349
2 DEEP VEIN THROMBOSIS POSTOPERATIVE 752 0.3754
3 C-REACTIVE PROTEIN 296 0.3193
4 LUPUS VULGARIS 387 0.3071
5 MEDICATION OVERUSE HEADACHE 236 0.2757
6 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 162 0.2425
7 SWOLLEN JOINT COUNT INCREASED 672 0.2105
8 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 410 0.1977
9 DISTURBANCE IN SOCIAL BEHAVIOUR 462 0.1959
See all enriched reactions for Central Nervous System Stimulant [EPC]